The stance taken by countries like Saudi Arabia on cannabis reflects a broader global debate about drug policy and human rights. Here are some key points to consider regarding the punitive measures for cannabis use in such countries:

1. Human Rights Violations: Harsh penalties for cannabis possession or use often lead to severe human rights abuses. People can face lengthy prison sentences, corporal punishment, or even the death penalty for relatively minor offenses, which many see as disproportionate and inhumane.

2. Misguided Priorities: Focusing on criminalizing cannabis detracts from more pressing social issues, such as healthcare, education, and economic development. It reflects an outdated view of drug use as a moral failing rather than a public health issue.

3. Lack of Scientific Basis: Numerous studies have shown that cannabis is less harmful than substances like alcohol and tobacco, which are legal and regulated in many countries. The demonization of cannabis fails to recognize its medicinal benefits and potential for responsible recreational use.

4. Global Shift: Many countries and regions are moving toward decriminalization and legalization, recognizing the economic benefits and public health implications of cannabis regulation. Countries that cling to harsh penalties risk falling behind in an evolving global landscape.

5. Social Justice: Punishing individuals for cannabis use often disproportionately affects marginalized communities, perpetuating cycles of poverty and discrimination. A more equitable approach would focus on education, treatment, and harm reduction rather than punishment.

6. Public Opinion: As societal attitudes shift toward acceptance of cannabis, rigid policies seem increasingly out of touch with the views of the younger population, who may see such laws as outdated and unjust.

In summary, punishing individuals for cannabis use, particularly in extreme ways, is increasingly viewed as an outdated and ineffective approach. Countries like Saudi Arabia might benefit from reconsidering their drug policies in light of scientific evidence, global trends, and fundamental human rights principles.